Wird geladen...
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9
The current method for creation of vaccinia virus (VACV) vectors involves using a selection and purification marker, however inclusion of a gene without therapeutic value in the resulting vector is not desirable for clinical use. The Cre-LoxP system has been used to make marker-free Poxviruses, but...
Gespeichert in:
| Veröffentlicht in: | Mol Ther Methods Clin Dev |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4571730/ https://ncbi.nlm.nih.gov/pubmed/26417609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2015.35 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|